Cancer Research 2010 AACR Elections  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yeh, T.-S.
Right arrow Articles by Lin, J.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yeh, T.-S.
Right arrow Articles by Lin, J.-J.
[Cancer Research 64, 8334-8340, November 15, 2004]
© 2004 American Association for Cancer Research


Regular Articles

Nuclear ßII-Tubulin Associates with the Activated Notch Receptor to Modulate Notch Signaling

Tien-Shun Yeh1, Rong-Hong Hsieh2, Shing-Chuan Shen3, Shwu-Huey Wang1, Min-Jen Tseng1,4, Chwen-Ming Shih5 and Jing-Jer Lin6

1 Graduate Institute of Cell and Molecular Biology and 2 Graduate Institute of Nutrition and Health Sciences, Taipei Medical University, Taipei, Taiwan; 3 Department of Dermatology, Taipei Municipal Wan-Fang Hospital-Affiliated with Taipei Medical University, Taipei, Taiwan; 4 Department of Life Science, National Chung Cheng University, Chia-Yi, Taiwan; 5 Department of Biochemistry, Taipei Medical University, Taipei, Taiwan; and 6 Institute of Biopharmaceutical Sciences, National Yang-Ming University, Taipei, Taiwan

The Notch signal pathway plays important roles in proliferation, apoptosis, and differentiation. Abnormalities in Notch signaling are linked to many human diseases. After ligand binding, Notch signaling is activated through the cleavage of Notch receptors to release and translocate the Notch intracellular domain into the nucleus. The Notch1 receptor intracellular domain (N1IC), the activated form of the Notch1 receptor, can modulate downstream target genes via C promoter-binding factor 1–dependent and -independent pathways. To further dissect the Notch1 signaling pathway, we screened the N1IC-associated proteins using a yeast two-hybrid system and identified nuclear ßII-tubulin as a candidate for the N1IC-associated proteins. It was suggested that the presence of ßII-tubulin in nuclei might be correlated with the cancerous state of cells. However, the function of ßII-tubulin locating in the nucleus still is unknown. Herein, we show that the complex of {alpha}- and ßII-tubulin is associated with N1IC in cancer cells by a coimmunoprecipitation analysis. The ankyrin domain of the Notch1 receptor alone was sufficient to associate with ßII-tubulin. Furthermore, {alpha}- and ßII-tubulin were localized in the nucleus and formed a complex with N1IC. Treatment with Taxol increased the amounts of nuclear {alpha}- and ßII-tubulin in K562 and HeLa cells and promoted the C promoter-binding factor 1–dependent transactivation activity of N1IC. We also show that nuclear ßII-tubulin was bound on the C promoter-binding factor 1 response elements via the association with N1IC. These results suggest that nuclear ßII-tubulin can modulate Notch signaling through interaction with N1IC in cancer cells.




This article has been cited by other articles:


Home page
Cancer Res.Home page
Y.-F. Lin, W.-P. Tsai, H.-G. Liu, and P.-H. Liang
Intracellular {beta}-Tubulin/Chaperonin Containing TCP1-{beta} Complex Serves as a Novel Chemotherapeutic Target against Drug-Resistant Tumors
Cancer Res., September 1, 2009; 69(17): 6879 - 6888.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. J. Lee, C. Chae, and M. M. Wang
p150/Glued Modifies Nuclear Estrogen Receptor Function
Mol. Endocrinol., May 1, 2009; 23(5): 620 - 629.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
T. Akoumianaki, D. Kardassis, H. Polioudaki, S. D. Georgatos, and P. A. Theodoropoulos
Nucleocytoplasmic shuttling of soluble tubulin in mammalian cells
J. Cell Sci., April 15, 2009; 122(8): 1111 - 1118.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
K.-W. Hsu, R.-H. Hsieh, Y.-H. W. Lee, C.-H. Chao, K.-J. Wu, M.-J. Tseng, and T.-S. Yeh
The Activated Notch1 Receptor Cooperates with {alpha}-Enolase and MBP-1 in Modulating c-myc Activity
Mol. Cell. Biol., August 1, 2008; 28(15): 4829 - 4842.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
W.-R. Liao, R.-H. Hsieh, K.-W. Hsu, M.-Z. Wu, M.-J. Tseng, R.-T. Mai, Y.-H. Wu Lee, and T.-S. Yeh
The CBF1-independent Notch1 signal pathway activates human c-myc expression partially via transcription factor YY1
Carcinogenesis, September 1, 2007; 28(9): 1867 - 1876.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.